Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Mohrbacher, M.D.
USC/Norris Cancer Hospital
Principal Investigator - Frits van Rhee, M.D.
Arkansas Cancer Research Center
Principal Investigator - Jeffrey A. Zonder, M.D.
Wayne State University
Principal Investigator - Robert Dean, MD
The Cleveland Clinic
Principal Investigator - Samer Al-Homsi, M.D.
University of Massachusetts Memorial Healthcare
Principal Investigator - Seema Singhal, M.D.
Northwestern University
Principal Investigator - William Bensinger, MD
Fred Hutchinson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center
Little Rock, Arkansas, United States
- Usc/norris Cancer Hospital
Los Angeles, California, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Massachusetts Memorial Healthcare- Univ. Campus
Worcester, Massachusetts, United States
- Wayne State University
Detroit, Michigan, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Aug 2008
- Completion
- 31 Jul 2009
- Last update posted
- 23 Sept 2009
- Registered enrollment
- 35
- Registry id
- NCT00425347
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.